When bone tumors were established (14 days after cell injection), half the PthlhWT mice started receiving intraperitoneally our anti‐PTHrP mAb and the other half a control IgG (three times per week, protocol diagram in Appendix S1, Fig S3A). The gene discussed is PTHLH; the disease is bone neoplasm.